Literature DB >> 2183815

Polyclonal antibodies to mannan from yeast also recognize the carbohydrate structure of gp120 of the AIDS virus: an approach to raise neutralizing antibodies to HIV-1 infection in vitro.

W E Müller1, H C Schröder, P Reuter, A Maidhof, G Uhlenbruck, I Winkler.   

Abstract

This study initiates a new method of developing an antigen which might be useful in the prevention of HIV-1 infection. Using a mannan preparation from Saccharomyces cerevisiae neutralizing antiserum was raised in rabbits which prevents HIV-1 infection in vitro up to a titre of 1:128. The corresponding antibody preparation neutralized the in vitro infectivity down to a concentration of 5 micrograms/ml. Analytical studies suggest that the antibodies are directed against the mannose residues of the HIV-1 glycoprotein (gp) 120 and its precursor gp 160.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2183815     DOI: 10.1097/00002030-199002000-00010

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  5 in total

1.  AIDS in Africa: distinguishing fact and fiction.

Authors:  E Papadopulos-Eleopulos; V F Turner; J M Papadimitriou; H Bialy
Journal:  World J Microbiol Biotechnol       Date:  1995-03       Impact factor: 3.312

2.  An O-linked carbohydrate neutralization epitope of HIV-1 gp 120 is expressed by HIV-1 env gene recombinant vaccinia virus.

Authors:  J E Hansen; H Clausen; S L Hu; J O Nielsen; S Olofsson
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160.

Authors:  A Benjouad; J C Gluckman; H Rochat; L Montagnier; E Bahraoui
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

4.  Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120.

Authors:  B M Curtis; S Scharnowske; A J Watson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

5.  Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160.

Authors:  A Benjouad; J C Gluckman; L Montagnier; E Bahraoui
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.